CROs – where is the money being spent?

another outsourcing/ offshoring issue...

05/12/2006 - The contract research organisation (CRO) industry is in full swing as the clinical trial outsourcing trend continues, but where is the money being spent?

Roughly 1,000 CROs are in operation across the world and this number continues to grow. The market is now worth $16bn (€12bn), according to research firm Datamonitor.
Giving a breakdown of this spending, 17 per cent of the total clinical research outsourced is preclinical work; six per cent is in Phase I; 14 per cent is during phase II-III and 16 per cent is postmarketing related.

Central lab services account for a further twelve per cent, while the remaining 28 per cent is being spent on other services such as data management and site management, according to figures from a 2004 Tufts University analysis.

Of the large global players, Quintiles is leading the pack, with 11 per cent of the global market share. Covance and Charles River laboratories share second spot, holding about eight per cent each, with PPD not far behind on seven per cent.

link to full article